52 research outputs found

    Braincase of panphagia protos (dinosauria, sauropodomorpha)

    Get PDF
    We describe a partial braincase of the basal sauropodomorph Panphagia protos from the Upper Triassic (midCarnian) horizons of the Ischigualasto Formation. The disarticulated braincase from a subadult individual includes one frontal, both parietals, one prootic, and the supraoccipital. The frontal is longer anteroposteriorly than it is wide transversely, has a small anterolateral process, and an elongate oval depression for the olfactory bulb. The supraoccipital is broader transversely than it is deep dorsoventrally and lacks a pronounced median nuchal eminence. Some braincase features that characterize more derived basal sauropodomorphs are not present in Panphagia, including a broader frontal and reduced anterior tympanic and floccular recesses. Panphagia appears to represent an early stage in the evolution of sauropodomorph dinosaurs.Describimos la caja craneana parcial del sauropodomorfo basal Panphagia protos proveniente de horizontes del Triásico superior (Carniano medio) de la Formación Ischigualasto. La caja craneana desarticulada es de un individuo sub-adulto e incluye un frontal, dos parietales, un proótico y el supraoccipital. El frontal es más largo anteroposteriormente que ancho transversalmente, tiene un pequeño proceso anterolateral y una depresión alargada oval para el bulbo olfatorio. El supraoccipital es transversalmente más ancho que dorsoventralmente alto y carece de una eminencia nucal media pronunciada. Algunas de las características que caracterizan los neurocráneos de sauropodomorfos basales más derivados no están presentes en Panphagia, incluyendo el frontal ancho y la reducción de las cavidades timpánica anterior y flocular. Panphagia parece representar una etapa temprana en la evolución de los dinosaurios sauropodomorfos.Fil: Martínez, Ricardo Néstor. Universidad Nacional de San Juan. Facultad de Ciencias Exactas, Fisicas y Naturales. Instituto y Museo de Ciencias Naturales; ArgentinaFil: Haro, Jose Augusto. Universidad Nacional de San Juan. Facultad de Ciencias Exactas, Fisicas y Naturales. Instituto y Museo de Ciencias Naturales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Apaldetti, Graciela Cecilia. Universidad Nacional de San Juan. Facultad de Ciencias Exactas, Fisicas y Naturales. Instituto y Museo de Ciencias Naturales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

    Non-chemical techniques used for the capture and relocation of wildlife in South Africa

    No full text
    Annually, thousands of game animals are captured and relocated across South Africa. One of the biggest causes of mortality during these translocations is stress, and as such it is the responsibility of all stakeholders involved to ensure that appropriate techniques are applied for specific species and environments. It is therefore important that there is a thorough understanding of these methods not only from a management perspective but also in terms of applied animal welfare. This review provides detailed descriptions of the various non-chemical techniques that may be employed during game capture and relocation in a South African context and highlights both species suitability, as well as the advantages and disadvantages of each technique. It also gives a brief background to the South African game capture industry as well as discussing and giving guidelines for the transportation and holding of wildlife after capture.Liesel L. Laubscher, Neville E. Pitts, Jacobus P. Raath, Louwrens C. Hoffma

    Validating a human biotelemetry system for use in captive blue wildebeest (Connochaetes taurinus)

    No full text
    We fitted two blue wildebeest (Connochaetes taurinus) with modified versions of the Equivital™ EQ02 wireless monitoring system to evaluate if the device could accurately measure heart rate and respiration rate in this species whilst anaesthetized as well as whilst fully conscious in captivity. Whilst under anaesthesia, we monitored each animal's heart rate and respiration rate using the Equivital™ biotelemetry belt, a Cardell(®) veterinary monitor and manual measurements. The animals were also administered doxapram hydrochloride (Dopram(®) ) and adrenaline intravenously at different times to stimulate changes in respiration and heart rate, respectively. Once 30 minutes of monitoring was completed, we reversed the anaesthetic and left the animals in captivity for 24 hours whilst wearing the Equivital™ belts. After 24 hr, we repeated the anaesthesia and monitoring as well as the administration of the doxapram hydrochloride and adrenaline. Intraclass Correlation Coefficients (ICC) calculated between all three monitoring methods showed moderate to excellent agreements for heart rate on both days (ICC: 0.73-0.98). ICCs calculated between the three methods for respiration rate showed good to excellent agreement between the Equivital belt and the other two methods (0.82-0.92) with the exception of occasions when only poor to fair agreements were found between the Cardell(®) measurements and manual measurements. Heart rate and respiration rate were also found to increase with motion while animals were in captivity. The results indicate that a modified version of the Equivital™ EQ02 system can be used as a potential biotelemetry device for measuring heart and respiration rate in captive blue wildebeest.Liesel L. Laubscher, Louwrens C. Hoffman, Neville I. Pitts and Jacobus P. Raat

    The effect and properties of drifts in the heliosphere

    No full text
    We investigate the properties of drifts and their effect on cosmic ray modulation in the heliosphere using a numerical modulation model based on the solution of a set of stochastic differential equations that was derived from the Parker transport equation. The illustrative capabilities of the numerical model are exploited to yield a better understanding of the physical modulation processes involved. Various studies have indicated that drifts need to be scaled down towards solar maximum conditions and the present study looks at how this can be achieved. Drifts are scaled down directly by multiplying the drift coefficient by a factor of less than unity as well as indirectly through the drift–diffusion relation, that is, by modifying the diffusion coefficient so as to cause a change in the drift effects through altered gradients in particle intensity. Contour plots of particle exit positions and exit energies are presented for both of these cases, and it is illustrated that drifts in the model lead to larger energy losses. This is explained with the aid of figures indicating the relative amount of time spent by pseudo-particles in different regions of the heliosphere during the modulation process. These figures also indicate that an increase in diffusion leads to a suppression or reduction of drift effects. Finally, the figures also show that drift effects are reduced as a function of increasing particle energy; even though the drift coefficient increases with particle energy, the total drift effect, taking into account the contribution from the increased diffusion associated with larger energies, causes drift effects to be reduced with an increase in energy

    Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project)

    No full text
    BACKGROUND: Due to a large variety in treatment outcomes reported in therapeutic trials and lacking patient‐relevant outcomes, it is hard to adequately compare and improve current therapies for patients with capillary malformations (CMs). The Core Outcome Set for Capillary Malformations (COSCAM) project aims to develop a core outcome set (COS) for use in future CM trials, in which we will first develop a core outcome (sub)domain set (CDS). Here, we describe the methods for the development of a CDS and present the results of the first development stage. METHODS: The COSCAM project is carried out according to the recommendations of the Cochrane Skin Core OUtcomes Set INitiative (CS‐COUSIN) and the Core Outcome Measures in Effectiveness Trials (COMET) initiative. During the first stage, we identified all potentially relevant outcome subdomains based on a systematic review, two focus group sessions and input from patient representatives of Dutch patient organizations and the COSCAM‐founding group. In stage two, we will present the subdomains in a three‐round e‐Delphi study and online consensus meeting, in which CM patients, parents/caregivers and CM experts worldwide rate the importance of the proposed subdomains, hereby finalizing the core outcome (sub)domains of the CDS. RESULTS: A total of 67 potential outcome subdomains were included; sixteen were previously used in the literature, 20 were proposed by Dutch patients and their parents/caregivers (n = 13) in focus group sessions and 38 were suggested by the experts of the COSCAM‐founding group. Seven were excluded because of overlap. CONCLUSION: The final CDS may serve as a minimum standard in future CM trials, thereby facilitating adequate comparison of treatment outcomes. After this CDS development, we will select appropriate outcome measurement instruments to measure the core outcome subdomains
    corecore